{"title":"[Berthold Kihn (1895-1964) and the NS \"Euthanasia\": Profile of a Perpetrator].","authors":"Birgit Braun, Nikolaus Knoepffler","doi":"10.1055/a-2066-0207","DOIUrl":"https://doi.org/10.1055/a-2066-0207","url":null,"abstract":"<p><strong>Introduction: </strong>In historical sciences, there is no consensus on how to understand the transition from eugenic sterilization to \"euthanasia\". The aim of this article was to investigate this question based on the historical-critical method, using the example of the perpetrator profile of Berthold Kihn. His pseudoscientific way to \"euthanasia\", however, did not have an eugenic foundation.</p><p><strong>Methods: </strong>Literature- and archival studies were carried out. For the first time, attention was paid to relevant Franconian and familial archival sources. Moreover, documents of the Jena University Archive were compared to those of the concentration camps of Buchenwald and Oranienburg.</p><p><strong>Results: </strong>After professional as well as private dilemma, the neuroinfectiologist Kihn set a focus on the \"eradication of the inferiors\". Apart from Kihn's role in central \"euthanasia\" and \"childrens' euthanasia\", which has been clearly demonstrated, we found actual hints of his additional involvement in decentral \"euthanasia\". This is shown using the example of the prominent patient Felix von Papen.</p><p><strong>Discussion: </strong>Kihn was no racial hygienist, he did not make his mark as an eugenicist. His professional and private dilemma may - among other things - have motivated him, to join a politically promoted movement.</p><p><strong>Conclusion: </strong>Further comparative research in the profiling of NS perpetrators may contribute to a better differentiation of the transition from eugenics to \"euthanasia\".</p>","PeriodicalId":12353,"journal":{"name":"Fortschritte Der Neurologie Psychiatrie","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49689585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Catharina Schmidt Schmidt, Natalia Anna Seeger, Nathalie Brackmann, Angela Guldimann, Elmar Habermeyer
{"title":"[Forensic-Psychiatric Consultations in General Psychiatry].","authors":"Catharina Schmidt Schmidt, Natalia Anna Seeger, Nathalie Brackmann, Angela Guldimann, Elmar Habermeyer","doi":"10.1055/a-2182-6606","DOIUrl":"10.1055/a-2182-6606","url":null,"abstract":"<p><p>A subgroup of psychiatric patients are at increased risk of committing interpersonal violence, which may lead to placements in forensic-psychiatric institutions. The majority of patients treated in forensic hospitals have had contact with the general psychiatric care system years before being forensically committed due to an offence. Nevertheless, attempts to establish models related to violence prevention in general psychiatry have remained sparse. In the Canton of Zurich, the forensic psychiatric consultation liaison service provides the general psychiatric clinics with access to forensic psychiatric expertise. In this paper, we describe the consultation service's diagnostic and advisory offers and aim to characterize the patient population seen by the service. We compared the three most common diagnostic groups (schizophrenic, affective and personality disorders) regarding reason for consultation, history of violence and substance abuse. In addition, we analyzed content and kind of the recommendations made. From 2013 to 2021, 188 patients in general psychiatric clinics in Zurich have been examined after informed consent. Most patients had a positive history of violence (72.7%) and substance use (66.1%). Almost half of the patients (48.4%) had been diagnosed with schizophrenia or a related disorder.</p>","PeriodicalId":12353,"journal":{"name":"Fortschritte Der Neurologie Psychiatrie","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49689586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mustafa Danışman, Gamze Zengin İspir, Ayşe Gül Yılmaz Özpolat
{"title":"Could Telling Parents About Substance Use Decrease Involvement in Crime of Substance Users?","authors":"Mustafa Danışman, Gamze Zengin İspir, Ayşe Gül Yılmaz Özpolat","doi":"10.1055/a-2165-8032","DOIUrl":"https://doi.org/10.1055/a-2165-8032","url":null,"abstract":"<p><strong>Introduction: </strong>Substance use disorder and criminal behaviors are increasing all over the world day by day. Factors that affect the involvement in crime among people with substance use disorders need to be examined more. This research aims to investigate the protective factors of substance users' involvement in crime and clarify the importance of telling parents about their substance use.</p><p><strong>Method: </strong>A total of 190 patients with substance use disorders were included. Patients were divided into two groups: those who told their families about their substance use (TP+) and those who did not tell (TP-). A sociodemographic data form, the short form of My Memories of Upbringing Scale for perceived parental attitudes, Experiences in Close Relationships Scale-Revised, and Emotional Autonomy Scale were used.</p><p><strong>Results: </strong>Our study found that people in the TP+group were less involved in crime than TP-. Telling rates increased proportionally when individuals' anxious attachment and individuation levels rose. In the TP+group, criminal history was correlated positively with substance use duration.</p><p><strong>Conclusion: </strong>Telling their families that they are using substances can be a protective factor in itself against crime among drug users, especially in the early stages of addiction. Professionals in addiction psychiatry should encourage their patients to tell their substance use. Teaching and encouraging them to communicate with their relatives might play a key role for policymakers while dealing with substance use disorders and related outcomes.</p>","PeriodicalId":12353,"journal":{"name":"Fortschritte Der Neurologie Psychiatrie","volume":" ","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49676093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Major Depression: Interaktionsanalyse von Metabolom und Darmmikrobiom","authors":"","doi":"10.1055/a-2080-1516","DOIUrl":"https://doi.org/10.1055/a-2080-1516","url":null,"abstract":"Der Begriff des Metaboloms beschreibt ein komplexes Reaktionsnetzwerk, das alle typischen Stoffwechselprozesse eines Organismus umfasst, und spiegelt somit den Gesamteffekt genetischer und umweltbedingter Einflüsse wider. Da sich der Ansatz zur Bewertung komplexer Erkrankungen eignet, haben Amin et al. mögliche Veränderungen und Interaktionen von Metabolom und Darmmikrobiom bei Menschen mit lebenslanger oder zeitweiser Major Depression analysiert.","PeriodicalId":12353,"journal":{"name":"Fortschritte Der Neurologie Psychiatrie","volume":"197 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135810670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[ICD-11 Between Development and Implementation].","authors":"Wolfgang Gaebel","doi":"10.1055/a-2124-6828","DOIUrl":"10.1055/a-2124-6828","url":null,"abstract":"Zum 1. Januar 2022 hat die WHO den Beginn des weltweiten Umstiegs von ICD-10 auf ICD-11 für die Berichterstattung zur Todesursachenstatistik anhand der neuen Mortality and Morbidity Statistics (MMS) festgesetzt und flexibel auf zunächst 5 Jahre terminiert.","PeriodicalId":12353,"journal":{"name":"Fortschritte Der Neurologie Psychiatrie","volume":"91 10","pages":"394-396"},"PeriodicalIF":0.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41233771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[New Therapeutic Approaches for Chronic Insomnia].","authors":"Moritz Brandt, Tony Sehr","doi":"10.1055/a-2055-5358","DOIUrl":"10.1055/a-2055-5358","url":null,"abstract":"<p><p>Insomnia represents one of the most common syndromes with far-reaching health and socioeconomic consequences. After a long period of stagnation, recent years have seen promising advances in the nonpharmacological and pharmacological treatment of patients with chronic insomnia. This article highlights these new therapeutic approaches in the context of established treatment options.</p>","PeriodicalId":12353,"journal":{"name":"Fortschritte Der Neurologie Psychiatrie","volume":"91 10","pages":"419-431"},"PeriodicalIF":0.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41233772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Max Hubert, Patricia Homeyer, Moritz D Brandt, Markus Donix, Robert Haußmann
{"title":"[Coincidence of normal pressure hydrocephalus and Alzheimer`s disease: therapeutic implications and open questions].","authors":"Max Hubert, Patricia Homeyer, Moritz D Brandt, Markus Donix, Robert Haußmann","doi":"10.1055/a-2107-9983","DOIUrl":"10.1055/a-2107-9983","url":null,"abstract":"<p><p>Normal pressure hydrocephalus (NPH) is prevalent in aging patient populations. Despite its clinical relevance, many patients with NPH may not receive adequate treatment. Because of the frequency of Alzheimer`s disease in these patients, there could be overlapping pathophysiological mechanisms that are as yet incompletely understood. Cerebral comorbidities seem to have negative effects on therapeutic response to ventriculoperitoneal shunting. In order to avoid unnecessary and unsuccessful surgery in highly vulnerable elderly patients, they have to be taken into consideration in the diagnostic process.</p>","PeriodicalId":12353,"journal":{"name":"Fortschritte Der Neurologie Psychiatrie","volume":" ","pages":"414-418"},"PeriodicalIF":0.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9873793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Max Beeke, Patricia Homeyer, Moritz D Brandt, Markus Donix, Robert Haußmann
{"title":"[Correction: Coincidence of normal pressure hydrocephalus and Alzheimer`s disease: therapeutic implications and open questions].","authors":"Max Beeke, Patricia Homeyer, Moritz D Brandt, Markus Donix, Robert Haußmann","doi":"10.1055/a-2212-7899","DOIUrl":"https://doi.org/10.1055/a-2212-7899","url":null,"abstract":"","PeriodicalId":12353,"journal":{"name":"Fortschritte Der Neurologie Psychiatrie","volume":"91 10","pages":"e3"},"PeriodicalIF":0.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138470180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Myasthenia gravis: Haben IVIG einen steroidsparenden Effekt?","authors":"","doi":"10.1055/a-2080-1314","DOIUrl":"https://doi.org/10.1055/a-2080-1314","url":null,"abstract":"Bei Myasthenia gravis (MG) werden zur symptomatischen Therapie primär Acetylcholinesterase-Inhibitoren eingesetzt. Sind diese nicht ausreichend wirksam, erfolgt eine Immunsuppression, häufig mit oralen Glukokortikosteroiden (GKS). Als Therapien der zweiten Wahl werden intravenöse Immunglobuline (IVIG) und Plasmapherese eingesetzt. Ob die Therapie mit IVIG bei steroidabhängiger MG einen GKS-sparenden Effekt hat, prüfte eine Phase-2-Studie.","PeriodicalId":12353,"journal":{"name":"Fortschritte Der Neurologie Psychiatrie","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135811466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Morbus Alzheimer: Lecanemab im frühen Krankheitsstadium?","authors":"","doi":"10.1055/a-2109-8823","DOIUrl":"https://doi.org/10.1055/a-2109-8823","url":null,"abstract":"Die Akkumulation von aggregiertem Amyloid-beta (Aβ) spielt in der Pathogenese von Morbus Alzheimer eine wichtige Rolle. Der humanisierte monoklonale IgG1-Antikörper Lecanemab bindet mit hoher Affinität an Aβ-lösliche Protofibrillen und gilt als möglicher Wirkstoff zur Behandlung von Betroffenen im Frühstadium. Van Dyck et al. haben Sicherheit und Wirksamkeit von Lecanemab geprüft und kommen in ihrer Phase-III-Studie zu einem gemischten Ergebnis.","PeriodicalId":12353,"journal":{"name":"Fortschritte Der Neurologie Psychiatrie","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135811455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}